Menu
GeneBe

rs41265017

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_022367.4(SEMA4A):c.2138G>A(p.Arg713Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0399 in 1,614,210 control chromosomes in the GnomAD database, including 1,578 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.033 ( 132 hom., cov: 32)
Exomes 𝑓: 0.041 ( 1446 hom. )

Consequence

SEMA4A
NM_022367.4 missense

Scores

1
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:13

Conservation

PhyloP100: 2.13
Variant links:
Genes affected
SEMA4A (HGNC:10729): (semaphorin 4A) This gene encodes a member of the semaphorin family of soluble and transmembrane proteins. Semaphorins are involved in numerous functions, including axon guidance, morphogenesis, carcinogenesis, and immunomodulation. The encoded protein is a single-pass type I membrane protein containing an immunoglobulin-like C2-type domain, a PSI domain and a sema domain. It inhibits axonal extension by providing local signals to specify territories inaccessible for growing axons. It is an activator of T-cell-mediated immunity and suppresses vascular endothelial growth factor (VEGF)-mediated endothelial cell migration and proliferation in vitro and angiogenesis in vivo. Mutations in this gene are associated with retinal degenerative diseases including retinitis pigmentosa type 35 (RP35) and cone-rod dystrophy type 10 (CORD10). Multiple alternatively spliced transcript variants encoding different isoforms have been identified.[provided by RefSeq, Sep 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0022318065).
BP6
Variant 1-156176849-G-A is Benign according to our data. Variant chr1-156176849-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 3362.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-156176849-G-A is described in Lovd as [Benign]. Variant chr1-156176849-G-A is described in Lovd as [Likely_pathogenic]. Variant chr1-156176849-G-A is described in Lovd as [Likely_benign].
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0827 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SEMA4ANM_022367.4 linkuse as main transcriptc.2138G>A p.Arg713Gln missense_variant 15/15 ENST00000368285.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SEMA4AENST00000368285.8 linkuse as main transcriptc.2138G>A p.Arg713Gln missense_variant 15/151 NM_022367.4 P1Q9H3S1-1
SEMA4AENST00000355014.6 linkuse as main transcriptc.2138G>A p.Arg713Gln missense_variant 15/151 P1Q9H3S1-1
SEMA4AENST00000368282.1 linkuse as main transcriptc.2138G>A p.Arg713Gln missense_variant 14/141 P1Q9H3S1-1
SEMA4AENST00000368284.5 linkuse as main transcriptc.1742G>A p.Arg581Gln missense_variant 13/132 Q9H3S1-2

Frequencies

GnomAD3 genomes
AF:
0.0326
AC:
4955
AN:
152214
Hom.:
132
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00743
Gnomad AMI
AF:
0.0241
Gnomad AMR
AF:
0.0385
Gnomad ASJ
AF:
0.103
Gnomad EAS
AF:
0.000577
Gnomad SAS
AF:
0.0376
Gnomad FIN
AF:
0.0291
Gnomad MID
AF:
0.133
Gnomad NFE
AF:
0.0447
Gnomad OTH
AF:
0.0478
GnomAD3 exomes
AF:
0.0374
AC:
9405
AN:
251410
Hom.:
279
AF XY:
0.0399
AC XY:
5424
AN XY:
135876
show subpopulations
Gnomad AFR exome
AF:
0.00671
Gnomad AMR exome
AF:
0.0309
Gnomad ASJ exome
AF:
0.0958
Gnomad EAS exome
AF:
0.000326
Gnomad SAS exome
AF:
0.0404
Gnomad FIN exome
AF:
0.0296
Gnomad NFE exome
AF:
0.0446
Gnomad OTH exome
AF:
0.0506
GnomAD4 exome
AF:
0.0407
AC:
59460
AN:
1461878
Hom.:
1446
Cov.:
34
AF XY:
0.0417
AC XY:
30353
AN XY:
727242
show subpopulations
Gnomad4 AFR exome
AF:
0.00747
Gnomad4 AMR exome
AF:
0.0317
Gnomad4 ASJ exome
AF:
0.0972
Gnomad4 EAS exome
AF:
0.000302
Gnomad4 SAS exome
AF:
0.0426
Gnomad4 FIN exome
AF:
0.0278
Gnomad4 NFE exome
AF:
0.0421
Gnomad4 OTH exome
AF:
0.0459
GnomAD4 genome
AF:
0.0325
AC:
4956
AN:
152332
Hom.:
132
Cov.:
32
AF XY:
0.0325
AC XY:
2422
AN XY:
74498
show subpopulations
Gnomad4 AFR
AF:
0.00743
Gnomad4 AMR
AF:
0.0384
Gnomad4 ASJ
AF:
0.103
Gnomad4 EAS
AF:
0.000579
Gnomad4 SAS
AF:
0.0381
Gnomad4 FIN
AF:
0.0291
Gnomad4 NFE
AF:
0.0447
Gnomad4 OTH
AF:
0.0473
Alfa
AF:
0.0464
Hom.:
297
Bravo
AF:
0.0319
TwinsUK
AF:
0.0348
AC:
129
ALSPAC
AF:
0.0384
AC:
148
ESP6500AA
AF:
0.00908
AC:
40
ESP6500EA
AF:
0.0478
AC:
411
ExAC
AF:
0.0354
AC:
4297
Asia WGS
AF:
0.0150
AC:
53
AN:
3478
EpiCase
AF:
0.0582
EpiControl
AF:
0.0551

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineApr 25, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in ESP (all): 451/13006=3.4% -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Sep 03, 2014- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 22, 2023- -
Benign, criteria provided, single submitterclinical testingGeneDxMay 25, 2018This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Retinitis pigmentosa 35 Uncertain:1Benign:1
Uncertain significance, no assertion criteria providedliterature onlyOMIMJan 01, 2013- -
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
Cone-rod dystrophy 10 Benign:2
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Retinitis Pigmentosa, Recessive Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Retinitis pigmentosa Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.34
Cadd
Uncertain
24
Dann
Uncertain
0.98
DEOGEN2
Benign
0.049
T;T;.;T;T
Eigen
Benign
-0.20
Eigen_PC
Benign
-0.064
FATHMM_MKL
Benign
0.57
D
MetaRNN
Benign
0.0022
T;T;T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
2.0
M;M;.;.;M
MutationTaster
Benign
0.15
P;P;P;P;P;P
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-0.37
N;N;N;.;N
REVEL
Benign
0.24
Sift
Benign
0.30
T;T;T;.;T
Sift4G
Benign
0.39
T;T;T;T;T
Polyphen
0.23
B;B;.;.;B
Vest4
0.068
MPC
0.21
ClinPred
0.0064
T
GERP RS
4.2
Varity_R
0.059
gMVP
0.32

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs41265017; hg19: chr1-156146640; COSMIC: COSV61772569; COSMIC: COSV61772569; API